Search

Abstract Hepatocellular carcinoma (HCC) is among the leading causes of mortality in the world. The detection of HCC in its early stage is the key for early treatment and thus the improvement of the chances of survival. Among the various methods of HCC screening, assays based on the detection of biomarker that is specific to HCC such as alpha- l -fucosidase (AFU) have been regarded as the most prominent methods. In this regards, a new assay for the detection of AFU to screen HCC was developed. This assay was based on the energy transfer between carbon dots (C-dots) and gold nanoparticles (AuNPs), the concentration of AFU could be monitored by the degree of C-dots fluorescence quenching due to the energy transfer. With this assay, a limit of detection of 3.4 nM (well below the diagnostic cutoff point of 80 nM), and a broad linear range of detection from 11.3 to 200 nM were achieved. We also demonstrate the determination of the concentration of AFU in human blood serum. Graphical abstract Image 1 Highlights • Energy transfer between carbon dots and AuNPs was used to design assay for the detection of alpha- l -fucosidase. • A sandwich assay was designed by combining polyclonal antibody coated AuNPs with monoclonal antibody attached to carbon dots. • A limit of detection of 3.4 nM and linear range from 11.3 to 200 nM were achieved. [ABSTRACT FROM AUTHOR]

The illicit use of anabolic androgenic steroids (AAS) as performance-enhancing drugs remains a global issue threatening not only the credibility of competitive sports but also public health due to the well-documented adverse effects they elicit. AAS abuse is not restricted only to professional sports, but also extends to recreational athletes and adolescents as well as in livestock production as growth-promoting agents. Testosterone and nandrolone are among the AAS most frequently exploited. Gas chromatography-mass spectrometry is the reference method for AAS detection, but it is strictly laboratory-based and cannot be performed on-site. The great potential of aptamers in bioanalytical applications and specifically for the development of simple analytical tools suitable for on-site analysis has been extensively documented. In this report, we describe the selection and identification of aptamers binding nandrolone, exhibiting affinity dissociation constants in the low nanomolar range. A label-free colorimetric assay based on gold nanoparticles was developed using one of these novel aptamers for the detection of nandrolone and/or its metabolites. The assay could be deployed for the rapid, on-site, facile and cost-effective screening of samples and provide qualitative visual results with a red to purple/blue color change being indicative of a positive result. [Display omitted] • Selection of novel aptamers binding to nandrolone by sepharose-SELEX. • High binding affinity of the selected aptamers demonstrated with different assays. • Development of a colorimetric gold nanoparticles-aptamer assay for nandrolone. • No cross-reactivity of the assay with endogenous steroids. • Use for screening suspicious samples for presence of nandrolone and its metabolites. [ABSTRACT FROM AUTHOR]